ZIM Laboratorie Standalone September 2020 Net Sales at Rs 86.45 crore, up 28.38% Y-o-Y
October 29, 2020 / 09:47 AM IST
Reported Standalone quarterly numbers for ZIM Laboratories Limited are:Net Sales at Rs 86.45 crore in September 2020 up 28.38% from Rs. 67.34 crore in September 2019.
Quarterly Net Loss at Rs. 0.06 crore in September 2020 up 88.19% from Rs. 0.49 crore in September 2019.
EBITDA stands at Rs. 11.33 crore in September 2020 up 134.09% from Rs. 4.84 crore in September 2019.
ZIM Laboratorie shares closed at 96.55 on October 28, 2020 (BSE)
| ZIM Laboratories Limited | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 86.45 | 69.77 | 67.34 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 86.45 | 69.77 | 67.34 | | EXPENDITURE | | Consumption of Raw Materials | 41.01 | 38.06 | 35.72 | | Purchase of Traded Goods | 2.09 | 1.75 | 0.57 | | Increase/Decrease in Stocks | 6.72 | -3.97 | -1.68 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.06 | 7.98 | 12.48 | | Depreciation | 3.54 | 3.56 | 3.16 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 17.40 | 16.22 | 15.84 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 7.63 | 6.17 | 1.24 | | Other Income | 0.17 | 0.64 | 0.44 | | P/L Before Int., Excpt. Items & Tax | 7.79 | 6.82 | 1.68 | | Interest | 2.67 | 2.94 | 3.17 | | P/L Before Exceptional Items & Tax | 5.13 | 3.88 | -1.49 | | Exceptional Items | -5.18 | -- | -- | | P/L Before Tax | -0.06 | 3.88 | -1.49 | | Tax | 0.00 | 1.11 | -1.01 | | P/L After Tax from Ordinary Activities | -0.06 | 2.77 | -0.49 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.06 | 2.77 | -0.49 | | Equity Share Capital | 16.24 | 16.24 | 16.18 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.03 | 1.70 | -0.30 | | Diluted EPS | -0.03 | 1.70 | -0.30 | | EPS After Extra Ordinary | | Basic EPS | -0.03 | 1.70 | -0.30 | | Diluted EPS | -0.03 | 1.70 | -0.30 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Is it safe to get vaccinated when you have COVID-19 symptoms? Doctors explain Watch more 
Centre not in favour of a 2020-kind of pan-India lockdown, says FM Nirmala Sitharaman Watch more 
Why are vaccinated people testing positive for COVID-19? Watch more 
Ideas for profit | Will road construction sector be able to repeat its performance of FY21? Watch more 
